Lyka Labs informs about integrated filing

05 Feb 2025 Evaluate
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated 2nd January, 2025, Lyka Labs has submitted the Integrated Filing (Financial) for the third quarter and nine months ended 31st December, 2024. The above information is also being made available on the Company’s website at www.lykalabs.com.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

77.80 1.34 (1.75%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×